Latest News

A new study from Yale researchers identifies an epithelial-immune signaling pathway crucial to the lung’s injury-repair process. When this signaling is altered, the study shows, it may help push the lung toward fibrosis.

When Naftali Kaminski, MD, was recruited to Yale in 2013 as section chief of Pulmonary, Critical Care and Sleep Medicine (Yale-PCCSM) he planned to lead it for 10 years. Now, coming up on his thirteenth year, he is stepping down at the end of June 2026.

Each year, the American College of Chest Physicians (CHEST) honors the clinicians, researchers, and educators shaping the future of chest medicine. Among this year’s distinguished honorees are several faculty members from the Section of Pulmonary, Critical Care, and Sleep Medicine at Yale School of Medicine (Yale-PCCSM), recognized for their leadership, innovation, and dedication to the field.

The Department of Internal Medicine welcomes the following new faculty, postdocs, and postgrads who joined the team in August 2025

A new Yale-led study sheds light on how asthma behaves differently in males and females, both in symptoms and at the level of gene expression.

Pulmonary fibrosis is a condition that causes scarring of the lungs. It is often accompanied by shortness of breath, cough, rapid loss of lung function, and respiratory failure.

Yale researchers developed an AI model that illuminates critical details about—and possible treatments for—idiopathic pulmonary fibrosis. It could do so for many other diseases.

Wonnie Ryu, MD, MPH, is the recipient of the American Thoracic Society (ATS) Assembly on Respiratory Cell and Molecular Biology Rising Star Award.

Twelve Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering.